Inventor · disambiguated record
Kevin D. Mccormick
Also filed as: MCCORMICK KEVIN D
45 granted patents·10 pending applications·846 citations·filing 1992–2016
98Inventor score
Files withSCHERING CORP30MERCK SHARP & DOHME4BOYCE CHRISTOPHER W3MCCORMICK KEVIN D3SCHERING PLOUGH CORP3
Top patents by PatentIndex Score
55 records- 0196US5795894APiperazino derivatives as neurokinn antagonistsSCHERING CORP·Filed 1996·Granted Aug 18, 1998·109 cites·8 claims
- 0294US5968929APiperazino derivatives as neurokinin antagonistsSCHERING CORP·Filed 1997·Granted Oct 19, 1999·70 cites·6 claims
- 0394US5691362ASubstituted benzene-fused hetero- and carbocyclics as nuerokinin antagonistsSCHERING PLOUGH CORP·Filed 1996·Granted Nov 25, 1997·89 cites·20 claims
- 0493US5869488APiperazino derivatives as neurokinin antagonistsSCHERING CORP·Filed 1996·Granted Feb 9, 1999·78 cites·6 claims
- 0590US7638531B2Phenoxypiperidines and analogs thereof useful as histamine H3 antagonistsSCHERING CORP·Filed 2006·Granted Dec 29, 2009·19 cites·18 claims
- 0690US7105505B2Benzimidazole derivatives useful as histamine H3 antagonistsSCHERING CORP·Filed 2003·Granted Sep 12, 2006·27 cites·22 claims
- 0790US6849621B2Piperidine compoundsSCHERING CORP·Filed 2002·Granted Feb 1, 2005·39 cites·28 claims
- 0889US6720328B2Non-imidazole compoundsSCHERING CORP·Filed 2001·Granted Apr 13, 2004·31 cites·43 claims
- 0988US8003624B2Functionally selective ALPHA2C adrenoreceptor agonistsSCHERING CORP·Filed 2007·Granted Aug 23, 2011·11 cites·7 claims
- 1087US7220735B2Benzimidazolone histamine H3 antagonistsSCHERING CORP·Filed 2003·Granted May 22, 2007·31 cites·18 claims
- 1186US6034251APhenyl-alkyl-imidazolesSCHERING CORP·Filed 1998·Granted Mar 7, 2000·38 cites·24 claims
- 1286US5696267ASubstituted oximes, hydrazones and olefins as neurokinin antagonistsSCHERING CORP·Filed 1996·Granted Dec 9, 1997·70 cites·23 claims
- 1385US7803828B2Functionally selective alpha2C adrenoreceptor agonistsSCHERING PLOUGH CORP·Filed 2006·Granted Sep 28, 2010·9 cites·17 claims
- 1484US8524697B2C20-C21 substituted glucocorticoid receptor agonistsANTHES JOHN C·Filed 2008·Granted Sep 3, 2013·20 cites·7 claims
- 1584US7700592B2α2C adrenoreceptor agonistsSCHERING CORP·Filed 2007·Granted Apr 20, 2010·8 cites·11 claims
- 1684US6951871B2Indole derivatives useful as histamine H3 antagonistsSCHERING CORP·Filed 2003·Granted Oct 4, 2005·21 cites·17 claims
- 1782US7879880B2Substituted aniline derivatives useful as histamine H3 antagonistsSCHERING CORP·Filed 2006·Granted Feb 1, 2011·5 cites·2 claims
- 1881US8383818B2Functionally selective alpha2C adrenoreceptor agonistsMERCK SHARP & DOHME·Filed 2009·Granted Feb 26, 2013·5 cites·4 claims
- 1981US7300941B2Non-imidazole compoundsSCHERING CORP·Filed 2003·Granted Nov 27, 2007·11 cites·2 claims
- 2080US7332604B21-[[1-[(2-Amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-b]pyridin-3-yl]piperidineSCHERING CORP·Filed 2006·Granted Feb 19, 2008·3 cites·1 claims
- 2179US7846946B2Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonistsSCHERING PLOUGH CORP·Filed 2009·Granted Dec 7, 2010·3 cites·2 claims
- 2278US8927559B2Quinazolinone-type compounds as CRTH2 antagonistsASLANIAN ROBERT G·Filed 2011·Granted Jan 6, 2015·6 cites·16 claims
- 2378US8592383B2Cycloalkyl-fused tetrahydroquinolines as CRTH2 receptor modulatorsHUANG XIANHAI·Filed 2012·Granted Nov 26, 2013·5 cites·48 claims
- 2477US10138212B2Aminoquinazoline compounds as A2A antagonistMERCK SHARP & DOHME·Filed 2016·Granted Nov 27, 2018·2 cites·18 claims
- 2575US7635705B2Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonistsSCHERING CORP·Filed 2006·Granted Dec 22, 2009·2 cites·19 claims
- 2674US6051575APiperazino derivatives as neurokinin antagonistsSCHERING CORP·Filed 1999·Granted Apr 18, 2000·15 cites·8 claims
- 2772US9469615B2Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulatorsBOYCE CHRISTOPHER W·Filed 2011·Granted Oct 18, 2016·4 cites·27 claims
- 2872US7985748B2ALPHA2C adrenoreceptor agonistsPHARMACOPEIA DRUG DISCOVERY·Filed 2010·Granted Jul 26, 2011·2 cites·15 claims
- 2972US5783579ASpiro-substituted azacyclic-substituted piperazino derivatives as neurokinin antagonistsSCHERING CORP·Filed 1996·Granted Jul 21, 1998·33 cites·6 claims
- 3071US7408066B2Carbon-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonistsSCHERING CORP·Filed 2006·Granted Aug 5, 2008·1 cites·9 claims
- 3171US5981520APiperazino derivatives as neurokinin antagonistsSCHERING CORP·Filed 1998·Granted Nov 9, 1999·13 cites·7 claims
- 3269US5840725ASubstituted oximes, hydrazones and olefins as neurokinin antagonistsSCHERING CORP·Filed 1997·Granted Nov 24, 1998·26 cites·20 claims
- 3366US8324213B2Biaryl-spiroaminooxazoline analogues as alpha 2C adrenergic receptor modulatorsMCCORMICK KEVIN D·Filed 2009·Granted Dec 4, 2012·1 cites·11 claims
- 3464US5438130AFucosylated guanosine disulfates as excitatory amino acid antagonistsCAMBRIDGE NEUROSCIENCE INC·Filed 1993·Granted Aug 1, 1995·18 cites·38 claims
- 3563US7238688B2Piperidine compoundsSCHERING CORP·Filed 2004·Granted Jul 3, 2007·1 cites·26 claims
- 3661US6762186B2Substituted imidazoles as dual histamine H1 and H3 agonists or antagonistsSCHERING CORP·Filed 2001·Granted Jul 13, 2004·1 cites·7 claims
- 3760US7531660B21-[[1-[(2-amino-6-methyl-4-pyridinyl)methyl]-4-fluoro-4-piperidinyl]carbonyl]-4-[2-(2-pyridinyl)-3H-imidazo[4,5-B]pyridin-3-YL]piperidine and methods of use thereofSCHERING CORP·Filed 2007·Granted May 12, 2009·0 cites·2 claims
- 3860US2008119487A1Novel non-imidazole compoundsSCHERING CORP·Filed 2007·Application pending·0 cites
- 3957US5892039APiperazino derivatives as neurokinin antagonistsSCHERING CORP·Filed 1996·Granted Apr 6, 1999·13 cites·1 claims
- 4055US8569312B2Biaryl-spiroaminooxzaoline analogues as alpha 2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2013·Granted Oct 29, 2013·0 cites·11 claims
- 4154US8476274B2Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulatorsMERCK SHARP & DOHME·Filed 2012·Granted Jul 2, 2013·0 cites·10 claims
- 4252US2011190247A1Cyclopropylchromene derivatives as modulators of the alpha-2c receptorSCHERING CORP·Filed 2009·Application pending·0 cites
- 4351US8017642B2Functionally selective ALPHA2C adrenoreceptor agonistsSCHERING CORP·Filed 2008·Granted Sep 13, 2011·0 cites·10 claims
- 4451US2007093477A1Alpha2C adrenoreceptor agonistsSCHERING CORP AND PHARMACOPEIA·Filed 2006·Application pending·0 cites
- 4550US8470863B2Derivatives and analogs of chroman as functionally selective ALPHA2C adrenoreceptor agonistsZHENG JUNYING·Filed 2008·Granted Jun 25, 2013·0 cites·14 claims
- 4650US5185365AInsect deterrent azamcrolidesCORNELL RES FOUNDATION INC·Filed 1992·Granted Feb 9, 1993·6 cites·12 claims
- 4749US2012028940A1Functionally selective azanitrile alpha-2c adrenoreceptor agonistsBOYCE CHRISTOPHER W·Filed 2009·Application pending·0 cites
- 4847US2011262368A1C21 thioethers as glucocorticoid receptor agonistsSCHERING CORP·Filed 2008·Application pending·0 cites
- 4946US2011166124A1Tricyclic spirocycle derivatives and methods of useMCCORMICK KEVIN D·Filed 2009·Application pending·0 cites
- 5045US2011130385A1Bicyclic Heterocylic Derivatives and Methods of UseDE LERA RUIZ MANUEL·Filed 2009·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kevin D. Mccormick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →